Caribou Biosciences

Caribou Biosciences: Series C Funding Round

Caribou Biosciences has successfully raised $304M in Series C funding, reaching a valuation of $1.2B.

Company Overview

CRISPR gene editing for cell therapies

Funding Details

The Series C round was led by RA Capital Management, with participation from Baillie Gifford, Redmile Group, Pfizer Ventures.

Company Information

• Headquarters: 2929 Seventh Street, Berkeley, CA 94710
• Founded: 2011
• Employees: 200+
• Category: Biotech

Investment

Caribou Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• RA Capital Management: Verified investor in Series C
• Baillie Gifford: Verified investor in Series C
• Redmile Group: Verified investor in Series C
• Pfizer Ventures: Verified investor in Series C